PME

Pingtan Marine Enterprise Ltd. (PME) | Rumor.io

Pingtan Marine Enterprise

PME

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)68%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about PME?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

May 18

Pro Medicus (PME) is considered a buy by experts from Wealthwise Education and Seneca Financial.
RBC Capital reports a 7-year $90m win with Beth Israel Lahey for Pro Medicus, implying ~$12.8m annualised revenue.
Pro Medicus has shown strong business performance despite a substantial share price decline, with potential for a strong rebound in the medium term.

Generated by AI

Sentiment

Of the messages about PME that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +64.75	82.15% -0.07
Bearish	—	—	0% -64.75	17.85% +0.07

Bullish· Jan 8

Pingtan Marine Enterprise Ltd. (PME) is poised for a big step in 2024, with a successful project in place.
PME's success is expected to drive growth and potentially lead to new opportunities in the future.
With a successful project already underway, PME is well-positioned to make significant strides in the coming year.

Bearish· May 10

$PME has been halted due to allegations of fraud, which may impact its trading and value.
The company has been accused of engaging in human trafficking, which raises concerns about its business practices and potential consequences.
$PME has experienced a significant decline in earnings, shifting from profitable to non-profitable, which may indicate a long-term decline in its value.

Generated by AI

Topics

Of the messages about PME that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	0%	0.62%
Macro	—	—	0%	95.18%
Earnings	—	—	0%	0%
Controversies	—	—	0%	0%
Announcements	—	—	100%	3.89%
Analysts	—	—	0%	0.3%

Jan 14

Pingtan Marine Enterprise Ltd. (PME) announces a 7-year, A$40M deal with Intermountain Healthcare, the largest healthcare provider in the Intermountain West (Utah, Idaho, Nevada).
PME's US subsidiary, Visage Imaging Inc., will replace legacy PACS under the contract.
PME updates FY 2021 guidance to at least 100% revenue increase, with EPS and revenue guidance now at $170 million.

Generated by AI

Community

Of the messages about PME, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	86.39%	29.53%
Newcomers	—	—	13.61%	70.47%

Regulars· Aug 18

Pro Medicus $PME is up 7% after its FY21 net profit rose 34% to $30.9M, with revenue increasing 20% to $67.9M, and a final dividend of 8cps declared.
Downgrades of Pro Medicus $PME to Sell with a $51.61 price target are based on the conclusion that the company's exceptional growth is already captured in the current price.
Pro Medicus $PME has reached a valuation of $6B, which is 200x PE, prompting a discussion about the valuation's reasonableness and the company's growth prospects.

Newcomers· Jul 2

PME's focus on the early fundamentals of the MOASS (Massive One-time Accumulation Swells) suggests a deep dive into the company's past performance.

Generated by AI

Also Discussed

Investors talking about PME also mention

#	Name	Attention
1	Nuveen New York Quality Municipal Income FundNAN	0%new
2	Carlisle Cos IncCSL	0%new
3	Five Point Holdings LLC Class A Common SharesFPH	0%new
4	Voc Energy TrustVOC	0%0
5	AHC - A. H. Belo Corporation	——
6	LOV - Spark Networks SE	——
7	REGI - Renewable Energy Group, Inc.	——
8	CHN - The China Fund, Inc.	——
9	James Hardie Industries plcJHX	0%new
10	KLR - Kaleyra, Inc.	——